首页|Martin Luther-University Halle-Wittenberg Reports Findings in Cancer (Advancing Anticancer Drug Discovery: Leveraging Metabolomics and Machine Learning for Mode of Action Prediction by Pattern Recognition)
Martin Luther-University Halle-Wittenberg Reports Findings in Cancer (Advancing Anticancer Drug Discovery: Leveraging Metabolomics and Machine Learning for Mode of Action Prediction by Pattern Recognition)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Cancer is the subject of a report.According to news originating from Halle Saale, Germany, by NewsRx correspondents, research stated, “A bottleneck in the development of new anti-ca ncer drugs is the recognition of their mode of action (MoA).Metabolomics combin ed with machine learning allowed to predict MoAs of novel anti-proliferative dru g candidates, focusing on human prostate cancer cells (PC-3).”
Halle SaaleGermanyEuropeAnticancer AgentsCancerCancer TherapyCyborgsDrugs and TherapiesEmerging Technolo giesHealth and MedicineMachine LearningOncologyProtective Agents
NETL
NSTL
